{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:28:15Z","timestamp":1772760495375,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.acra.2019.12.009","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T08:17:14Z","timestamp":1580113034000},"page":"1580-1585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance"],"prefix":"10.1016","volume":"27","author":[{"given":"Vignesh","family":"Selvakumaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sora C.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata V.","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler P.","family":"Litton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Xiangxi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Devalapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Scott","family":"Soo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Y.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars J.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2019.12.009_bib0001","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Available at: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/breast-cancer-facts-and-figures-2017-2018.pdf. Accessed: April 17, 2019."},{"issue":"41","key":"10.1016\/j.acra.2019.12.009_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: terminology, classification, and natural history","volume":"2010","author":"Allred","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"11","key":"10.1016\/j.acra.2019.12.009_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-015-0473-x","article-title":"Ductal carcinoma in situ: treatment update and current trends","volume":"17","author":"Mitchell","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.acra.2019.12.009_bib0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.acra.2019.12.009_bib0005","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.acra.2019.12.009_bib0006","first-page":"17","article-title":"Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies","volume":"9","author":"Nounou","year":"2015","journal-title":"Breast Cancer (Auckl)"},{"issue":"5","key":"10.1016\/j.acra.2019.12.009_bib0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10731199.2010.494578","article-title":"Advances in novel drug delivery strategies for breast cancer therapy","volume":"38","author":"Dhankhar","year":"2010","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"7","key":"10.1016\/j.acra.2019.12.009_bib0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/M13-2548","article-title":"Prioritization of research addressing management strategies for ductal carcinoma in situ","volume":"160","author":"Gierisch","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.acra.2019.12.009_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/djp485","article-title":"National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009","volume":"102","author":"Allegra","year":"2010","journal-title":"J Natl Cancer Inst."},{"issue":"12","key":"10.1016\/j.acra.2019.12.009_bib0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ\u2014The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.acra.2019.12.009_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clon.2014.09.015","article-title":"The LORIS Trial: addressing overtreatment of ductal carcinoma in situ","volume":"27","author":"Francis","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.acra.2019.12.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.acra.2019.12.009_bib0013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jemt.10180","article-title":"Histologic classification of ductal carcinoma in situ","volume":"59","author":"Jaffer","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"10","key":"10.1016\/j.acra.2019.12.009_bib0014","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/crad.2001.0779","article-title":"Predicting invasion in mammographically detected microcalcification","volume":"56","author":"Bagnall","year":"2001","journal-title":"Clin Radiol"},{"issue":"7","key":"10.1016\/j.acra.2019.12.009_bib0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jso.20445","article-title":"Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only","volume":"93","author":"Dillon","year":"2006","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.acra.2019.12.009_bib0016","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archsurg.2010.243","article-title":"Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ","volume":"145","author":"Kurniawan","year":"2010","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.acra.2019.12.009_bib0017","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiology.217.2.r00nv08466","article-title":"Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?","volume":"217","author":"Lee","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.acra.2019.12.009_bib0018","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ejrad.2015.12.027","article-title":"Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components","volume":"85","author":"Lee","year":"2016","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.acra.2019.12.009_bib0019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.crad.2008.08.007","article-title":"Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy","volume":"64","author":"O'Flynn","year":"2009","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.acra.2019.12.009_bib0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.23273","article-title":"Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy","volume":"107","author":"Park","year":"2013","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.acra.2019.12.009_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5858\/2002-126-0039-PIITES","article-title":"Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ","volume":"126","author":"Renshaw","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.acra.2019.12.009_bib0022","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.crad.2014.12.019","article-title":"Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme","volume":"70","author":"Sim","year":"2015","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.acra.2019.12.009_bib0023","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jmri.25655","article-title":"Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?","volume":"46","author":"Harowicz","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.acra.2019.12.009_bib0024","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.acra.2019.12.009_bib0025","series-title":"ACR BI-RADS\u00ae Mammography. ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System","author":"Sickles","year":"2013"},{"key":"10.1016\/j.acra.2019.12.009_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10.1016\/j.acra.2019.12.009_bib0027","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.acra.2019.12.009_bib0028","unstructured":"Breast Cancer Staging, 7th Edition. Available at: https:\/\/cancerstaging.org\/references-tools\/quickreferences\/Documents\/BreastMedium.pdf. Accessed June 27, 2019."},{"issue":"4","key":"10.1016\/j.acra.2019.12.009_bib0029","first-page":"290","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.acra.2019.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.acra.2017.03.013","article-title":"Can occult invasive disease in ductal carcinoma in situ be predicted using computer-extracted mammographic features?","volume":"24","author":"Shi","year":"2017","journal-title":"Acad Radiol."},{"issue":"3 Pt B","key":"10.1016\/j.acra.2019.12.009_bib0031","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jacr.2017.11.036","article-title":"Prediction of occult invasive disease in ductal carcinoma in situ using deep learning features","volume":"15","author":"Shi","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"10.1016\/j.acra.2019.12.009_bib0032","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.acra.2019.12.009_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/1754-9485.12430","article-title":"DCIS of the breast: the value of preoperative MRI","volume":"60","author":"Doyle","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"5","key":"10.1016\/j.acra.2019.12.009_bib0034","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12149-018-1251-2","article-title":"Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer","volume":"32","author":"Yoo","year":"2018","journal-title":"Ann Nucl Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633219306233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633219306233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:48:34Z","timestamp":1761036514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633219306233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1076633219306233"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2019.12.009","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}